Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors.
Paul JohannetSomer AbdelfattahCallahan WildeShrey PatelHenry S WalchBenoit RousseauGuillem ArgilésOliver ArtzMiteshkumar PatelAndrea ArfeAndrea CercekRona YaegerKaruna GaneshNikolaus SchultzLuis A DiazMichael B FootePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
mut tumors exhibit a conserved molecular and clinical phenotype defined by mucinous tumor status, increased peritoneal metastasis, poor response to first-line systemic therapy, and worse survival.